We are pleased to announce the release of a new episode in the RESISTALKs podcast series.

Episode Title:

Discussing the BEATLE trial “Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: a randomised, multicentre, open label superiority clinical trial”, findings and reflections.

Featured Speakers:

• Dr. Júlia Laporte Amargos (Bellvitge University Hospital, Spain)
• Prof. Mark Gilchrist (Imperial College London, UK)
• Chaired by Prof. David Paterson

Together, they delve into the BEATLE trial findings, which compared extended infusion and bolus infusion of antibiotics in patients with febrile neutropenia. While extended infusion demonstrated improved pharmacokinetics, the overall treatment outcomes were similar between the two groups.

Access this podcast to gain key insights on managing febrile neutropenia, early antibiotic de-escalation, and diagnostic challenges.

Access here: ad-id.co/4eBkytq